What type of drug is Bavencio?
Medically reviewed by Drugs.com. Last updated on Jul 2, 2020.
Bavencio (avelumab) is a programmed death ligand-1 (PD-L1) blocking antibody.
Bavencio targets the PD-L1 receptors, which are protein receptors on cell surfaces. When Bavencio blocks PD-L1, it 'turns on' the ability of cancer-fighting cells such as T-cells to attack and kill tumors.
Bavencio is used for the treatment of: